Form 8-K Avalanche Biotechnologie For: May 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
Avalanche Biotechnologies (AAVL) Misses Q1 EPS by 18c
May 6, 2016 7:15 AM EDTAvalanche Biotechnologies (NASDAQ: AAVL) reported Q1 EPS of ($0.57), $0.18 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $265 thousand versus the consensus estimate of $400 thousand.
For earnings history and earnings-related data on Avalanche Biotechnologies (AAVL) click here.
... More


